Harbour Investments, Inc. Haemonetics Corp Transaction History
Harbour Investments, Inc.
- $3.26 Billion
- Q4 2024
A detailed history of Harbour Investments, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Harbour Investments, Inc. holds 60 shares of HAE stock, worth $3,750. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60
Previous 25
140.0%
Holding current value
$3,750
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HAE
# of Institutions
343Shares Held
52.6MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$373 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$324 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$276 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$265 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.55MShares$160 Million0.12% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.21B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...